Tower Research Capital (TRC)’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-140,126
| Closed | -$1K | – | 4736 |
|
|
2019
Q1 | $1K | Buy |
140,126
+92,888
| +197% | +$23.7K | ﹤0.01% | 3706 |
|
|
2018
Q4 | $5K | Buy |
+47,238
| New | +$31K | ﹤0.01% | 2982 |
|
|
2018
Q3 | – | Sell |
-100
| Closed | – | – | 4557 |
|
|
2018
Q2 | $0 | Sell |
100
-2,409
| -96% | -$4.17K | ﹤0.01% | 4363 |
|
|
2018
Q1 | $5K | Buy |
+2,509
| New | +$5.3K | ﹤0.01% | 2756 |
|
|
2017
Q4 | – | Sell |
-1,632
| Closed | -$5K | – | 4349 |
|
|
2017
Q3 | $5K | Buy |
+1,632
| New | +$5.57K | ﹤0.01% | 3352 |
|
|
2017
Q1 | – | Sell |
-14,422
| Closed | -$88K | – | 4381 |
|
|
2016
Q4 | $88K | Buy |
14,422
+14,087
| +4,205% | +$73.6K | 0.01% | 1047 |
|
|
2016
Q3 | $2K | Buy |
335
+196
| +141% | +$918 | ﹤0.01% | 3194 |
|
|
2016
Q2 | $1K | Buy |
139
+14
| +11% | +$47 | ﹤0.01% | 4298 |
|
|
2016
Q1 | $0 | Sell |
125
-6,046
| -98% | -$21.9K | ﹤0.01% | 5374 |
|
|
2015
Q4 | $35K | Buy |
+6,171
| New | +$37.6K | 0.01% | 768 |
|
|
2015
Q3 | – | Sell |
-5,186
| Closed | -$43K | – | 5181 |
|
|
2015
Q2 | $43K | Buy |
+5,186
| New | +$25.1K | ﹤0.01% | 1491 |
|
|
2015
Q1 | – | Sell |
-5,038
| Closed | -$15K | – | 5207 |
|
|
2014
Q4 | $15K | Buy |
5,038
+1,689
| +50% | +$5K | ﹤0.01% | 1822 |
|
|
2014
Q3 | $9K | Buy |
+3,349
| New | +$12.1K | ﹤0.01% | 2930 |
|
|
2013
Q4 | – | Sell |
-9,508
| Closed | -$43K | – | 5131 |
|
|
2013
Q3 | $43K | Buy |
9,508
+7,442
| +360% | +$33.4K | ﹤0.01% | 2056 |
|
|
2013
Q2 | $9K | Buy |
+2,066
| New | +$10.4K | ﹤0.01% | 2498 |
|
Tower Research Capital (TRC)'s SGYP Position: Q2 2019 in Review
Tower Research Capital (TRC) sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2019, closing a stake of 140,126 shares — an estimated $1K sold.
Tower Research Capital (TRC) first reported a position in SGYP in Q2 2013 and held it in 15 quarters. The position peaked at $88K in Q4 2016. 2 funds tracked by Wall St. Rank hold SGYP as of Q2 2019.
- Tower Research Capital (TRC) reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2019 after selling out during the quarter.
- Tower Research Capital (TRC) sold 140,126 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2019, an estimated $1K.
- Tower Research Capital (TRC) first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 15 quarters.
- Tower Research Capital (TRC)'s Synergy Pharmaceuticals, Inc Common Stock position peaked at $88K in Q4 2016.
- 2 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2019.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.